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Abstract
Background: Adoption of contemporary evidence-based guidelines for acute stroke management is often delayed
due to a range of key enablers and barriers. Recent reviews on such barriers focus mainly on specific acute stroke
therapies or generalised stroke care guidelines. This review examined the overall barriers and enablers, as perceived
by health professionals which affect how evidence-based practice guidelines (stroke unit care, thrombolysis
administration, aspirin usage and decompressive surgery) for acute stroke care are adopted in hospital settings.
Methodology: A systematic search of databases was conducted using MEDLINE, Cumulative Index to Nursing and
Allied Health Literature (CINAHL), Embase, PsycINFO, Cochrane Library and AMED (Allied and Complementary Medicine
Database from 1990 to 2016. The population of interest included health professionals working clinically or in roles
responsible for acute stroke care. There were no restrictions to the study designs. A quality appraisal tool for qualitative
studies by the Joanna Briggs Institute and another for quantitative studies by the Centre for Evidence-Based Management
were used in the present study. A recent checklist to classify barriers and enablers to health professionals’ adherence to
evidence-based practice was also used.
Results: Ten studies met the inclusion criteria out of a total of 9832 search results. The main barriers or enablers identified
included poor organisational or institutional level support, health professionals’ limited skills or competence to use a
particular therapy, low level of awareness, familiarity or confidence in the effectiveness of a particular evidence-based
therapy, limited medical facilities to support evidence uptake, inadequate peer support among health professionals’,
complex nature of some stroke care therapies or guidelines and patient level barriers.
Conclusions: Despite considerable evidence supporting various specific therapies for stroke care, uptake of these
therapies is compromised by barriers across organisational, patients, guideline interventions and health professionals’
domains. As a result, we recommend that future interventions and health policy directions should be informed by these
findings in order to optimise uptake of best practice acute stroke care. Further studies from low- to middle-income
countries are needed to understand the barriers and enablers in such settings.
Trial registration: The review protocol was registered in the international prospective register of systematic reviews,
PROSPERO 2015 (Registration Number: CRD42015023481)
Keywords: Acute stroke, Evidence-based practice, Therapies, Services, Barriers, Enablers
* Correspondence: leonard.baatiema@acu.edu.au
1Regional Institute for Population Studies, University of Ghana, P.O Box LG96,
Legon-Accra, Ghana
2School of Allied Health, Faculty of Health Sciences, Australian Catholic
University, Sydney, Australia
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Baatiema et al. Implementation Science  (2017) 12:74 
DOI 10.1186/s13012-017-0599-3
Background
Translation of research evidence into clinical practice is
a major imperative for health professionals in policy,
management and research, worldwide. It is almost half a
century since Cochrane challenged conventional health
care practices which consequently paved the way for the
present day evidence-based practice movement in medi-
cine and health care [1]. Nonetheless, routine clinical
practice still lags behind contemporary research evi-
dence [2–4], despite international calls for research
evidence to guide healthcare delivery [5]. Globally, there
is no single solution to closing this knowledge to prac-
tice gap [4, 6, 7]. In general, it has been estimated to
take about 17 years for research evidence to be trans-
lated into clinical practice [8]. Delays in the adoption of
evidence-based practice could be attributed to a multi-
plicity of barriers [9–12] underpinned by a plethora of
theoretical and conceptual perspectives [2, 3, 13, 14],
which have emerged to shed light on these barriers or
enablers.
Stroke is caused by an interruption or blockage in
blood supply or arterial bleeding into or around the
brain [15, 16]. The early stages (first 48 h) of an acute
stroke are a critical time-window for appropriate inter-
ventions to either stop or slow down brain tissue decay
and minimise mortality and morbidity [17]. To provide
acute stroke care in the early stages, current recommen-
dations from Level-1 evidence for best practice include
(1) stroke care in a specialist stroke unit [18, 19], (2)
thrombolytic therapy with intravenous tissue plasmino-
gen activator (t-PA) within 4.5 h of an acute ischemic
stroke [20–22], (3) aspirin administration within 48 h of
acute ischemic stroke onset [23–25] and (4) decom-
pressive surgery if required within 48 h of stroke onset
[26, 27]. The use of t-PA for example is the most effect-
ive pharmacological therapy for acute ischemic stroke
despite the persistence of controversies surrounding its
usage. First reported by the National Institute of Neuro-
logical Disorders and Stroke (NINDS) trials with a treat-
ment window of 3 h [22], a later trial extended the
treatment time to 4.5 h upon acute ischemic stroke [21].
Given such evidence consistently showed sound clinical
outcomes over time, clinical guidelines have been devel-
oped and continually updated to support the application
of these interventions for improved patient outcomes
[28–34]. However, despite this scientific evidence and in-
creased support for their usage, translation into clinical
practice is slow, and this is greatest in low–middle in-
come countries [35–37]. For example, despite the net
benefits associated with thrombolytic therapy for acute
ischemic stroke, global uptake in low-income countries
is about 3% compared to 50% in high-income countries
[35]. A recent survey of acute stroke services in eleven
major referral hospitals in Ghana also revealed the lack
of use of t-PA for acute ischemic stroke care and the
availability of only one stroke unit [38].
The reasons for the slow uptake remains poorly under-
stood. Some studies have however attempted to shed light
on such barriers, and these comprised inadequate medical
facilities for acute stroke care, health professionals’ un-
willingness for change, unawareness of evidence-based
therapies, lack of health professionals’ competence to
apply evidence-based therapies, limited staff capacity
and decision-makers’ values and preferences could be
attributed for the slow uptake [39–46]. Such barriers
have resulted in the underutilisation of best practice in-
terventions towards positive clinical outcomes. The re-
cent Lancet series on Right Care [47], which seeks
among others, to highlight the chronic underutilization
of evidence-based interventions further underscores the
centrality of this review.
To date, no study has attempted to systematically ana-
lyse published primary studies on the barriers and en-
ablers perceived by health care professionals to influence
the adoption of these four highly recommended acute
stroke therapies or services. Prior studies on this topic
were either limited in focus by only unilaterally explor-
ing barriers related to the use of t-PA [41, 42, 44], neu-
roprotective therapy [45] or generalised acute stroke
care guidelines [40]. A recent study by Craig et al. has
also attempted to examine some of these barriers and
enablers [48], though an important contribution, a dif-
ferent theoretical framework was used, and focused
more on clinical behavioural components.
Our aim in this review was to identify health profes-
sionals’ views on the barriers and enablers to their use of
the above recommended evidence-based acute stroke
care interventions. An understanding of these barriers
and enablers is important towards closing the current
knowledge to practice gap in stroke clinical practice.
With the increasing stroke burden in low–middle income
regions in recent times [49–51] and where uptake levels
of such interventions are presently lowest, a clearer under-
standing of barriers and enablers, primarily from such re-
gions may also be essential in developing context-specific
strategies to optimise uptake of evidence-based acute
stroke care recommendations in clinical practice to
improve patient outcomes.
Methods
This review was conducted according to the Preferred
Reporting Item for Systematic Reviews and Meta-
Analysis (PRISMA) systematic review approach [52], as
outlined in Additional file 1. The review protocol was
registered in the international prospective register of
systematic reviews, PROSPERO 2015 (Registration
Number: CRD42015023481).
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Eligibility criteria
Studies based on the views of stroke specialists, medical
doctors, nurses and allied health professionals were
considered. Other health professionals including health
managers, health planners, health policy-makers or any
health executives’ about barriers or enablers to the up-
take of evidence-based acute stroke care were included.
For inclusion, interventions for evidence-based acute
stroke care were restricted to barriers or enablers in re-
lation to the provision of care in a stroke unit, thrombo-
lytic therapy, the use of aspirin and decompressive
surgery. Peer-reviewed articles of any study design were
considered. Barriers and enablers based on database re-
cords were excluded. Included studies were based only on
the views, opinions and experiences of the health profes-
sionals. Non-original research such as letters, commentar-
ies, guidelines, magazines and editorials were excluded.
Research studies with non-human components were also
not considered.
Search strategy
A systematic search of the literature was conducted
electronically using MEDLINE, CINAHL, Embase, Psy-
cINFO, Cochrane Library and AMED. Reference lists
and bibliographies from eligible studies published from
1990 to 2016 were also considered for inclusion. The
review considered studies published within this time
duration to correspond with the period when evidence-
based medicine movement and scholarship enjoyed
renewed interest and acknowledgement [53]. This was
also done to ensure included studies reflect current evi-
dence of health professionals’ views on what acts as a
barrier or an enabler to their uptake or adherence to
evidence-based practice for acute stroke care. Due to
lack of resources for language translation, all included
studies were limited to studies published in English lan-
guage. Search strings were designed to reflect related
Medical Subject Heading (MeSH) terms, key terms
and phrases from the selected databases related to
the review aim. Details of the search terms used are
presented in Additional file 2.
Study selection
Results were downloaded and imported into EndNote
for screening to first remove duplicates by one author
(LB). The next stage involved the screening of the
remaining studies based on the relevance of study titles
and abstracts to the review aim. When articles had in-
sufficient information in the title and abstract to support
this screening, a full-text reading was conducted. This
was followed by the selection of all potentially eligible
studies in full text. A second author (SS) reviewed the
selected full-text articles to ensure they met the eligibil-
ity criteria. Results of the full text were also shared with
the remaining authors to validate, and none of the
authors raised questions about their eligibility. Articles
which met the inclusion criteria following full-text
screening by two authors (LB and SS) were selected for
the final analysis.
Data extraction
A standardised data extraction tool (evidence table) was
used to extract information relevant to the study aim by
one author (LB). As shown in Table 1, the information
extracted include the authors and year of publication,
country of study, intervention, study aim, design, partici-
pants/sample, data collection methods and key findings
on the barriers and enablers to uptake of acute stroke
care interventions. This was systematically done to en-
sure extracted data characteristics from the eligible stud-
ies were consistent. The key findings and conclusions of
the eligible studies which were reported as either bar-
riers, enablers or barriers and enablers were identified by
one author (LB). These findings were shared with the
remaining reviewers to ensure consistency with the
primary studies.
Data synthesis
Data analysis involved a thematic analysis of the results
from the eligible studies. Based on the Tailored Imple-
mentation for Chronic Diseases project [54], a pre-
existing framework of seven domains developed by
implementation science researchers to examine what in-
forms change in clinical practice [55] was followed to
categorise the themes of barriers and enablers. The
checklist of seven domains comprised guideline factors,
individual health professionals’ factors, patient factors,
professional interactions, incentives and resources, cap-
acity for organisational change, and social, political and
legal affairs. Additional file 3 provides further explan-
ation of each domain. This process was done by one re-
viewer (LB) who is experienced in categorising themes
using pre-existing frameworks. This was done with con-
stant reference to the content of the pre-existing frame-
work and identified barriers and enablers from the
articles to ensure appropriate classification. Another re-
viewer (SS) validated the classification of the barriers
and enablers (See Table 2), and one disagreement was
recorded during this stage but was quickly resolved in
consultation with another author (AdGA). One author
(LB) consequently weighted each domain of barriers/en-
ablers in a tabular form (See Table 3) according to the
frequency of each barrier or enabler as reported in the
articles.
Assessment of methodological quality
To capture the unique reporting differences within
qualitative and quantitative studies, two separate quality
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reporting assessment tools were used. The checklist by
the Joanna Briggs Institute for assessing qualitative stud-
ies was used for the qualitative studies [56], while the
guidelines suggested by the Centre for Evidence-Based
Management to appraise surveys was also used for the
quantitative studies [57]. These checklists were used be-
cause they have comprehensively clear score sheets and
instructions which enabled the authors to assess the
relevance and rigour of all included studies. Given that
there is still lack of consensus on the criteria for asses-
sing the quality of qualitative studies in systematic re-
views [58, 59]; included qualitative studies were not
based on their quality scoring but on the basis of their
overall contribution to the synthesis rigour. One re-
viewer (LB) appraised the quality of included studies.
Another reviewer (SS) carried out a separate rating and
slight variations were observed. However, these differ-
ences were quickly addressed by the two reviewers.
Results
Study selection
The electronic search yielded 9832 studies [MEDLINE=2518,
CINAHL = 458, AMED = 221, PscINFO = 1229, Embase
= 873, Cochrane Library = 4507 and 26 additional stud-
ies retrieved from other sources]. After removing 1386
duplicates, 8446 studies remained. Screening based on
title and abstract relevance excluded 8263 and 81arti-
cles, respectively. Studies excluded at this stage were
either due to the fact that they were not primary
studies, had irrelevant topics, that is, not focused on
barriers and enablers to the four recommended evidence-
based stroke care interventions. Other reasons for exclu-
sion include duplicate studies, letters and editorials. A
full-text screening of the remaining 102 potentially eligible
studies led to further exclusions of 92 studies as they were
deemed irrelevant to the study aim, focused on different
population of interest, included review papers, guidelines
and case reports. Overall, 10 studies met the inclusion
criteria (See Fig. 1).
Study characteristics
Three qualitative [60–62] and seven quantitative studies
[63–69] were included. Quantitative studies employed
online and postal surveys while the qualitative studies
used semi-structured interviews and focus group
methods. Whereas analysis of the quantitative studies
was conducted using predominantly descriptive statis-
tics, thematic analysis guided the analyses of the qualita-
tive studies. The total number of included participants
was 1692, and these comprised nurses, general medical
doctors, neurologists, emergency department physicians,
allied health staff and health managers. Included studies
were published between 2004 and 2015. Four studies
were conducted in Australia [62, 64, 66, 69], three in the
USA [60, 63, 65], two in Sweden [61, 67], and one each
in Norway [67], Denmark [67] and the Netherlands [68].
Most of the barriers or enablers identified in the quanti-
tative studies were also found in the qualitative studies.
Studies predominantly examined the barriers or enablers
to the use of thrombolysis [60, 61, 63–65, 67, 69]. One
study focused exclusively on barriers related to the estab-
lishment of a stroke unit [66], another on the uptake of
both aspirin and thrombolysis [68] and the remaining on
stroke unit and thrombolysis [62]. Although most of the
eligible studies focused on barriers related to the use of
evidence-based care for acute stroke, all included studies
reported on three or more related barriers or enablers
(See Table 1 for additional information).
Table 2 Domain of barriers or enablers to evidence uptake
Author and year Stroke therapy
or intervention
Guideline
factors
Individual health
professionals
Patient
factors
Professional
interactions
Incentives and
resources
Capacity for
organisational
change
Social, political
and legal factors
O’Rourke (2013) [66] Stroke unit x x x x
Grady (2014) [64] Thrombolysis x x x
William (2013) [69] Thrombolysis x x x x
Van Der (2004) [68] Aspirin and thrombolysis x x x x x
Slot (2009) [67] Thrombolysis x x x x x
Meurer (2011) [60] Thrombolysis x x x x x
Purvis (2014) [62] Stroke unit and
thrombolysis
x x x x x x
Stecksén (2013) [61] x x x x x
Hargis (2015) [65] Thrombolysis x x x x x x
Chan (2005) [63] Thrombolysis x x x x
X indicates a particular thematic barrier or enabler reported by the author (s)
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Quality assessment
The overall quality of the quantitative studies was
moderate given that certain methodological limita-
tions were found in the eligible studies. Only one
study described in detail the sampling of study sub-
jects and employed sampling techniques to minimise
selection bias [69]. However, the rest of the cross sec-
tional studies did not include substantive information
on sampling techniques used to minimise selection
bias. Three of the eligible studies reported high re-
sponse rates of 91 [63], 92 [67] and 95.8% [66]. Con-
versely, low response rates of 13 [64] and 26% [69]
were also noted. Details of quality of reporting evalu-
ations are presented in Table 4.
On the other hand, none one of the eligible qualitative
studies reported on theoretical or philosophical bases for
methodological choice, limiting the ability to situate and
assess methodological relevance. However, there was a
common approach to the reporting of specific data col-
lection and the analysis process. However, none of the
studies reported on how the philosophical paradigm in-
fluenced data analysis and interpretation. All qualitative
studies adequately described how interviews were
conducted, although no assessment data trustworthiness
through triangulation or member checking was reported.
Finally, two of the qualitative studies [48, 62] addressed
the issue of reflexivity, that is, potential reporting bias
related to the researcher’s professional background or
areas of interest.
Synthesis of results
Summary of evidence: main barriers and enablers to
evidence uptake
Overall, four studies reported on both barriers and en-
ablers to uptake of evidence-based acute stroke therapies
[61, 62, 66, 69] whilst five reported on only barriers to
evidence uptake [60, 63, 65, 67, 67] and one study had
an explicit focus on enablers to uptake of evidence-
based care for acute stroke [63]. Despite some studies
reporting on both barriers and enablers, studies which
focused only on barriers often made reference to or
inferred enablers as the opposite of the barriers, an ap-
proach that has been adopted in the present review.
Thus, barriers and enablers were analysed and discussed
collectively. As reported below, Table 3 shows the
Fig. 1 Flow chart on selection and screening process for eligible studies using the PRISMA methods
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distribution and weighted frequency of each barrier
which provides information on the potential significance
of each barrier and enabler to the uptake of the four rec-
ommended acute stroke care interventions.
Capacity for organisational change
This category of barriers/enablers was the most highly
cited by participants in all the eligible studies. According
to the health professionals, the use of evidence-based
care could be challenged by lack of institutional support
[61]. They further highlighted limited health staff cap-
acity especially lack of a stroke nurse or specialist [60,
62, 65] and inadequate funding opportunities for staff
professional development [62, 64]. For example, partici-
pants reported that some hospitals were unable to
provide or formalise acute stroke care guidelines to
facilitate health staff use of evidence-based therapies
[60, 69]. Additionally, instances were cited where
there was limited or no executive support for professional
development or upgrading to deliver current therapies for
acute stroke according to best scientific evidence [62]. Of
the varied barriers reported under this category, workload
demands were also commonly cited as a key hindrance to
the implementation of evidence-based acute stroke care
[60, 62, 67]. In one study [69], 71% of participants indi-
cated lack of protocols and pathways. The study by Van
der Weijden et al. identified organisational level barriers
as the most significant barriers to uptake of evidence-
based practice [68].
Individual health professionals
Individual health professionals’ factors were reported by
participants as important barriers/enablers from the eli-
gible studies. This domain of barriers was found in nine
included studies [60–65, 67–69]. In the views of most
participants, uptake of evidence-based interventions
such as thrombolytic therapy is slow or not happening
due to health professional’s lack of awareness of a
particular intervention [60, 61, 68, 69], lack of skills or
self-efficacy to apply the intervention [60, 61, 68] or low
motivation to implement an evidence-based therapy
[60]. For example, in one study, 50% of participants indi-
cated their lack of knowledge on the use of thrombolytic
therapy hampered uptake in their routine clinical
practice [60]. They also outlined barriers such as old-
fashioned views about some specific acute stroke therap-
ies [61]. Further, one study [63] reported that some
neurologists disapprove of the use of thrombolytic ther-
apy, which was agreed by (33%) of respondents.
Resources and incentives
This was another major domain of barriers or enablers
to evidence uptake for acute stroke care. A total of eight
of ten eligible studies identified resources and incentives
related barriers/enablers as crucial to evidence uptake
[60–63, 65–68]. Some of the common barriers/enablers
comprised limited physical space to establish stroke
units [66], lack of CT scans [63], lack of financial re-
sources [61, 62, 66, 68], limited time [61, 66], limited
stroke beds [62, 66] and limited staff capacity [61–63,
66, 68]. These factors were common in both qualitative
and quantitative studies in this review.
Guidelines factors
The present review has shown the nature and character-
istics of specific evidence-based therapies for acute
stroke could influence their levels of uptake. Nine of ten
eligible studies reported barriers related to the character-
istics or the nature of evidence related to the stroke
intervention or guidelines [60–63, 65–69]. Views related
more to health professionals’ misconceptions about the
level of effectiveness of some acute stroke care therapies
such as thrombolysis. For example, despite evidence that
the benefits of thrombolysis outweigh potential associ-
ated side effects, participants expressed doubts in the
effectiveness of this therapy because they were con-
cerned about severe bleeding and other complications.
In one study [69], 73% of respondents indicated risk of
symptomatic intracerebral haemorrhage as a key barrier
to administering thrombolysis. In another study [63],
33% of the participants expressed uncertainty about the
evidence of using thrombolytic therapy for acute ische-
mic stroke and recommended the need for further
studies for definitive evidence of its efficacy before they
would use it for patient care. Disagreement on the rec-
ommended dosage for aspirin was also highlighted by
participants in one study [68].
Patient factors
Within this domain of barriers and enablers, six studies
highlighted factors such as late arrival to seek care, pa-
tients’ or relatives’ lack of awareness of early stroke
symptoms or patients’ decision for other acute care in-
terventions outside the standardised recommendation
Table 3 Barriers and enablers to evidence-based acute stroke
care
Domain of barriers and enablers Frequency (%)
Guideline factors 16 (10.38%)
Individual health professionals 39 (25.32%)
Patient factors 15 (9.74%)
Professional interactions 10 (6.49%)
Incentives and resources 17 (11.03%)
Capacity for organisational change 57 (37.01%)
Social, political and legal factors 0 (0.0%)
Note: The weighted frequency was calculated based on the number of times a
particular barrier or enabler was reported in the eligible studies
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[60, 62, 66, 67–69]. The most frequently reported
patient-related barrier was patients’ late arrival in emer-
gency departments to receive thrombolysis. For example,
one study [69] reported that 91% of respondents
indicated patients’ late arrival for acute care as the major
barrier. Another study ranked delayed patient
presentation for care as the major barrier to the use of
thrombolytic therapy [65] due to the patients’ failure to
recognise stroke symptoms. Another key barrier was
patients’ preference for the non-use of thrombolysis as
a therapeutic option due to perceived side-effects of
this treatment option [67].
Table 4 Critical appraisal of eligible studies
Appraisal questions for survey O’Rourke
(2013) [66]
William
(2013) [69]
Van Der Weijden
(2004) [67]
Grady
(2014) [64]
Hargis
(2015) [65]
Chan
(2005) [63]
Slot
(2009)
[67]
1 Did the study address a clearly focused question/issue? Y Y Y Y Y Y Y
2 Is the research method (study design) appropriate for
answering the research question?
Y Y Y Y Y Y Y
3 Is the method of selection of the subjects (employees,
teams, divisions, organisations) clearly described?
U Y Y Y Y N Y
4 Could the way the sample was obtained introduce
(selection) bias?
N N N N U N N
5 Was the sample of subjects representative with regard
to the population to which the findings will be referred?
N N N Y N N Y
6 Was the sample size based on pre-study considerations
of statistical power?
N Y Y N N N N
7 Was a satisfactory response rate achieved? Y N N N Y Y Y
8 Are the measurements (questionnaires) likely to be
valid and reliable?
N Y N Y N N N
9 Was the statistical significance assessed? N N N Y N N N
10 Are confidence intervals given for the main results? N N Y N N N N
11 Could there be confounding factors that haven’t
been accounted for?
N N N N N N U
12 Can the results be applied to your organisation? N U U N N N Y
Yes (Y), Can’t Tell (U) and NO (N)
Critical Appraisal Questions for Qualitative Studies Meurer
(2011) [60]
Purvis
(2014) [62]
Stecksén (2013)
[61]
1 Is there a congruity between the stated philosophical
perspective and the research methodology?
N N N
2 Is there a congruity between the research methodology
and the research question or objectives?
Y Y Y
3 Is there a congruity between the research methodology
and the methods used to collect the data?
Y Y Y
4 Is there a congruity between the research methodology
and the representation and analysis of data?
Y Y Y
5 Is there a congruity between the research methodology
and the interpretation of results?
Y Y Y
6 Is there a statement locating the researcher culturally
or theoretically?
Y Y N
7 Is the influence of the researcher on the research and
vice versa addressed?
U Y U
8 Are participants, and their voices, adequately
represented?
Y Y N
9 Is the research ethical according to current criteria or, for
recent studies, is there evidence of ethical approval by
an appropriate body?
Y Y Y
10 Do the conclusions drawn in the research report flow
from the analysis, or interpretation, of the data?
Y Y Y
Yes (Y) No (N) Unclear (U) Not Applicable (NA)
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Professional interactions
The uptake of evidence-based care for acute stroke can
also be influenced by the form and nature of interactions
among health professionals, especially engagement with
clinical leaders. Five studies showed evidence of this do-
main of barriers/enablers [61, 62, 64–66]. The present
review found this as among the least described barriers/
enablers in the included studies. Barriers suggested by
participants included: inadequate communication espe-
cially among clinical staff [65], lack of clinical leadership
or support from senior clinicians [62]. As an example,
Hargis et al. reported that 14% of respondents cited poor
communication between emergency department staff,
and the neurology team affected the use of thrombolytic
therapy [65].
Discussion
This review aimed to explore the main barriers/enablers
underlying adoption of evidence-based therapies for
treatment and management of acute stroke. To date,
prior studies have focused largely on barriers or enablers
to generalised acute stroke guidelines or thrombolysis spe-
cifically. This review addressed a knowledge gap on the
main barriers or enablers to the uptake of the four recom-
mended evidence-based therapies/service for acute stroke,
namely, stroke unit care, thrombolytic therapy, aspirin
and decompressive surgery.
The specific innovations of this review are its primary
focus on the four recommended evidence-based therap-
ies for acute stroke care and the inclusion of both quan-
titative and qualitative study designs, both of which add
depth to the analysis. Although this review was limited
to ten eligible studies, there seems to be a saturation of
potential determinants given the commonality and re-
currence of barriers and enablers revealed between stud-
ies. There was also a significant overlap in the reported
barriers or enablers, although these characterisations
differed between health professionals. Findings from
prior reviews on barriers to thrombolysis uptake [41, 44,
45, 70], other studies on the barriers and enablers to
triaging, treatment and patients’ transfer in emergency
departments (ED) [48] and adherence to general stroke
clinical guidelines [40], corroborated with majority of
the barriers/enablers identified in this review.
On the most important barriers or enablers from the
present review, organisational context or structural level
factors were the most cited barriers or enablers to uptake
of evidence-based care for acute stroke by health profes-
sionals. This finding substantiates the results of earlier
works [9, 41, 70]. Given the importance attached to this
category of barriers and as reflected in earlier works, a
greater effort to address these barriers should be prioritise
by health managers and planners for optimal uptake of
evidence-based practice. Further, consistent with the
literature [9, 40, 41, 45, 71], the barriers related to the in-
dividual health professional and guideline level barriers,
availability of adequate health resources and medical facil-
ities were also predominant in this review.
The barriers/enablers associated with social, political
and legal factors were not reported by any of the eligible
studies, thus leaving a gap in our understanding of
whether such thematic barriers or enablers play any im-
portant role in evidence-based care uptake. It is plausible
that their influence on evidence-uptake is negligible and
may not warrant immediate attention of health policy-
makers and health managers. The absence of evidence for
this domain of barriers/enablers in this review was also
evident in the checklist employed to contextualise the dis-
cussion in this review. In that review [55], which promul-
gated the checklist, this particular domain attracted the
least eligible studies.
Importantly, the eligible studies were all conducted in
high-income countries and so the findings may not be dir-
ectly relevant to those in low–middle income countries.
The inadequacy of medical facilities, limited health staff
capacity and other health resource constraints charac-
terised in low- and middle-income countries may emerge
as the most important barrier since health systems in
these contexts always have fewer resources overall com-
pared to high-income countries.
This review has also underscored the need for increased
attention on patient level barriers. Specifically, patients’
late arrival in ED settings for care because of lack of rec-
ognition of early stroke symptoms was notable. To ad-
dress the low awareness or lack of early recognition of
stroke symptoms, we recommend the need for increased
public health campaigns and research emphasising the ur-
gent need to seek care at stroke symptom onset, as
highlighted by the ‘time is brain’ research study [72] and
the ‘FAST’ stroke awareness campaign messages in the
UK [73, 74]. The UK FAST stroke awareness campaign
strategy could be a unique exemplar for low- and middle-
income countries where evidence [75–77] suggest low
awareness of stroke symptoms is a major obstacle to care.
With the exception of thrombolytic therapy, the barriers
or enablers on the remaining three evidence-based recom-
mendations were less explored. No studies explored
decompression surgery, although an earlier review sug-
gested patient level barriers as more essential [45]. Other
researchers have cited limited access to computed tomo-
graphic (CT) brain scans in low-middle income as the
most important factors to address to improve uptake of
aspirin therapy [78].
Implications
The analysis from this review may inform the circum-
stances in which health professionals are able to provide
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evidence-based care for acute stroke patients. Despite
the increased scholarship and policy recommendations
for this, the reported barriers or enablers persist, conse-
quently depriving patients of sound and effective therap-
ies. Given that previous evidence suggest, overall, a
significant number of patients receive clinical care with-
out sound scientific evidence [2, 10, 79], these findings
have the potential to contribute to present efforts aimed
at ensuring stroke patients receive effective care.
Increasingly, reports of the rising incidence and mor-
tality rates from stroke in low- and middle-income
countries continue to attract the attention of global
health authorities. Nonetheless, studies thus far have in-
dicated a low uptake of evidence-based care for acute
stroke in Africa and other low/middle income regions
[35, 36]. However, no eligible studies were found in low-
and middle-income countries to improve understanding
about the factors accounting for this apparent gap. It is
essential to explore the barriers or enablers in the
context of Africa and other low- and middle-income
regions to develop context-specific interventions to en-
hance uptake of evidence-based care for acute stroke.
Various health professionals play major primary roles
as acute caregivers and consequently have unique chal-
lenges that deserve attention in future studies since this
review was unable to separate determinants according to
specific health professionals. Future research should en-
deavour to explore the barriers or enablers unique to
stroke specialists, medical doctors, nurses and allied
health staff. As emphasised earlier, identifying the views
of stroke patients and carers on the barriers and enablers
to stroke care should be part of future research efforts.
Strengths and limitations
An important strength of this review is its primary focus
on the four recommended evidence-based care interven-
tions. The inclusion of both quantitative and qualitative
study designs further adds to the analytical breadth and
depth of this review. Nonetheless, this review has some
limitations. First, we acknowledge that since this study
was limited to studies published in English language, there
remains a possibility other relevant studies and insights
from LMIC were missed. Also, the screening process for
eligible studies was conducted by a single author, and this
may have affected the accuracy, reliability and transpar-
ency of the process. Additionally, the search for relevant
studies was limited to only peer-reviewed journals thus
potentially relevant theses, conference presentations and
book chapters were excluded. Although, the reasons for
the lack of studies from low- and middle-income coun-
tries remains unclear, this could be explained by the
prevailing situation of limited international literature on
the uptake of evidence-based acute stroke care interven-
tions from such settings.
The limited number of eligible studies made it impos-
sible to draw definitive conclusions about the primary bar-
riers or enablers to evidence uptake for acute stroke care.
Also, although the present study attempted to rank the
importance of the barriers and enablers based on their
weighted frequencies, this is not optimal. This field is less
developed with currently no time-tested approaches to
qualitatively rate the importance of such drivers to change
in healthcare. Approaches such as the GRADE-CERQual
framework to measure the confidence of synthesised evi-
dence [80] could be explored in similar reviews in future.
As we used a pre-designed taxonomy of barriers and en-
ablers to contextualise our findings, it is possible other
relevant barriers and enablers considered unfit to the
framework were inadvertently missed out.
Conclusions
The reported barriers or enablers mapped well with the
previously proposed taxonomy of barriers or enablers.
Our findings are consistent with previous studies [9, 40]
where lack of adherence to or inadequate use of evidence-
based care was attributed to organisational level factors,
professionals’ lack of awareness and familiarity to a par-
ticular evidence-based care, financial constraints, lack of
confidence in a particular therapy, fear of adverse effects,
personal beliefs, patient delays, lack of time to implement
evidence-based treatment guidelines and preferences or
values about the use of evidence-based care.
Despite considerable effective therapeutic options for
acute stroke care, poor understanding of barriers or en-
ablers and lack of a clear evidence-based health policy to
ensure their uptake render such therapeutic services
underutilised. In light of this, efforts by health managers
and policy-makers to formulate context-specific policies
and design interventions to enhance uptake of evidence-
based care should be informed by these barriers and
enablers. Following this review, we are also proposing
research studies be conducted in low-middle income
countries to enhance our understanding of the key bar-
riers accounting for the currently low uptake levels of
evidence-based acute stroke care interventions.
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